Company profile for PeptiDream

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

PeptiDream Inc. is a public (Tokyo Stock Exchange 1st Section 4587) biopharmaceutical company founded in 2006 employing our proprietary Peptide Discovery Platform System(PDPS), a state-of-the-art highly versatile discovery platform which enables the production of highly diverse (trillions) non-standard peptide libraries with high efficiency, for the identification of highly potent and selective hit candidates, which then can b...
PeptiDream Inc. is a public (Tokyo Stock Exchange 1st Section 4587) biopharmaceutical company founded in 2006 employing our proprietary Peptide Discovery Platform System(PDPS), a state-of-the-art highly versatile discovery platform which enables the production of highly diverse (trillions) non-standard peptide libraries with high efficiency, for the identification of highly potent and selective hit candidates, which then can be developed into peptide-based, small molecule-based, or peptide-drug-conjugate-based therapeutics. PeptiDream aspires to be a world leader in drug discovery and development to address unmet medical need.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Japan
Address
Address
210-0821 3-25-23 Tonomachi, Kawasaki-ku, Kawasaki City, Kanagawa Prefecture
Telephone
Telephone
+81-44-270-1300
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/15/3166805/0/en/Curium-Group-PeptiDream-and-PDRadiopharma-Enroll-First-Patient-to-Registrational-Clinical-Trial-of-64Cu-PSMA-I-T-for-Prostate-Cancer-in-Japan.html

GLOBENEWSWIRE
15 Oct 2025

https://www.businesswire.com/news/home/20250328335990/en/National-Cancer-Center-Japan-and-PeptiDream-New-Radiopharmaceuticals-for-Renal-Cell-Carcinoma

BUSINESSWIRE
28 Mar 2025

https://www.businesswire.com/news/home/20241212633930/en

BUSINESSWIRE
12 Dec 2024

https://www.businesswire.com/news/home/20241212512779/en

BUSINESSWIRE
12 Dec 2024

https://www.globenewswire.com//en/news-release/2024/10/01/2956017/0/en/Curium-Announces-Strategic-Partnership-with-PeptiDream-for-Prostate-Cancer-Theranostics-in-Japan.html

GLOBENEWSWIRE
01 Oct 2024

https://www.businesswire.com/news/home/20240604805068/en

BUSINESSWIRE
04 Jun 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty